
RARE vs SVRA
$RARE vs $SVRA head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
RARE vs SVRA: the quick read
- ·RARE is the larger company by market cap ($1.27B vs $1.05B).
- ·RARE has been more active on our scanner (260 vs 56 alerts in 30 days).
- ·RARE has the smaller float (98.6M vs 152.5M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·RARE draws far more of our scanner's attention, 260 unusual-volume alerts in 30 days against 56, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 20% of each other on market cap, which makes the rest of this table the interesting part.
- ·They are pulling apart today: RARE is outperforming the other by roughly 9.8 percentage points on the session.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing RARE and SVRA on TheDesperateTrader.
- Is RARE or SVRA the better stock?
- "Better" depends on your goal, and these two are not alike. RARE is the larger company by market cap ($1.27B vs $1.05B). RARE has been more active on our scanner (260 vs 56 alerts in 30 days). RARE has the smaller float (98.6M vs 152.5M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between RARE and SVRA?
- The differences that matter: they are not in the same business - RARE is pharmaceutical preparations and SVRA is pharmaceutical preparations; they are similar in size ($1.27B vs $1.05B); they trade at very different share prices ($14.87 vs $5.42); RARE sits at 8% of its 52-week range against 57% for SVRA; our scanner flagged RARE 260 times in the last 30 days against 56 for SVRA. Everything above is measured from the latest completed session and SEC filings.
- Which of RARE and SVRA is more active right now?
- Right now RARE is at about 1.3x its normal volume and SVRA is at about 0.8x, so RARE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading RARE or SVRA? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore RARE and SVRA comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.